Researchers examined real-world characteristics of patients receiving albuterol multidose dry powder inhaler or short-acting β2 agonists with short-acting β2 agonists. More patients using albuterol ...

Please provide your email address to receive an email when new articles are posted on . Patients who used the Reliever Digihaler System had greater odds for better asthma control compared with ...

person holding blue asthma inhaler Researchers examined real-world characteristics of patients receiving albuterol multidose dry powder inhaler or short-acting β2 agonists with short-acting β2 ...

Asthma is a common lung condition that affects 5.4 million people in the UK and can lead to symptoms such as coughing, wheezing or feeling breathless. Asthma is best controlled by regular use of a ...

The drugs regulator has issued a warning to healthcare professionals not to prescribe salbutamol or terbutaline inhalers without an inhaled corticosteroid. A drug safety update from the Medicines and ...

As reliever monotherapy for mild asthma, the inhaled corticosteroid (ICS)-formoterol combination reduced asthma attacks in children compared with a short-acting β₂-agonist (SABA), the CARE trial ...

Please provide your email address to receive an email when new articles are posted on . Rates of overprescribing of short-acting beta agonist asthma inhalers remain high and vary significantly among ...

What to do when a patient’s asthma control deteriorates after switching to a more environmentally friendly, or ‘greener’, ...

Asthma is a chronic lung condition characterized by inflammation and narrowness in the airways that carry air in and out of the lungs. About 1 in 13 people in the United States are affected by asthma.

Researchers have found that more than a quarter of asthma patients are still over-using inhalers intended for rapid relief of symptoms. Overuse of these inhalers is linked to an increased risk of ...